
MRC-backed lung cancer study points to a possible new way to catch the disease earlier
An MRC-backed study suggests clearing immune fog could help stop lung cancer before diagnosis.

An MRC-backed study suggests clearing immune fog could help stop lung cancer before diagnosis.

New Nature findings show durable progress in gene and cell therapy, from hemophilia B gene therapy to long-term CAR-T persistence.

UKHSA is expanding wastewater surveillance to spot major health threats earlier and strengthen public health monitoring.

Nature Medicine reports an early randomized trial of inhaled siRNA targeting RAGE for pulmonary inflammation.

Nature Medicine reports an early randomized trial of inhaled siRNA targeting RAGE for pulmonary inflammation.

A new study says pathology should be embedded early in cancer trial design to improve feasibility and trial quality.

New BMJ research explores intravenous iron before cardiac surgery and what it could mean for pre-operative anaemia care.

Paxlovid did not improve Long COVID symptoms in a large NIH-funded trial published in Lancet Infectious Diseases.

Mayo Clinic researchers report a new strategy that may help CAR-T therapy work better against thyroid cancer.

Protein-proximity therapies are advancing after the first approved PROTAC for breast cancer, signaling a new phase in precision medicine.

Researchers identify activated dendritic cells as key to anti-cancer immunity, opening new possibilities for immunotherapy.

England is rolling out precision radiotherapy for prostate cancer, cutting treatment sessions from 20 to five.